Abbott Laboratories (ABT) recently swept its monthly fair value gap and saw a significant price increase from $102 to $104 on Friday. Despite the jump, there was no specific news driving this above-average ATR daily movement. The stock has been holding above the $100 level, building a solid base, and the chart looks promising. With earnings due on July 18, it's worth monitoring, though no trade will be entered yet. Keep an eye on further developments as the earnings date approaches.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。